Compare SIF & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIF | PLUR |
|---|---|---|
| Founded | 1913 | 2001 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 33.9M |
| IPO Year | 1995 | 2001 |
| Metric | SIF | PLUR |
|---|---|---|
| Price | $13.27 | $3.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 156.2K | 6.4K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.67 | 10.78 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $111,212,000.00 | $1,336,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | N/A | $293.97 |
| P/E Ratio | $44.14 | ★ N/A |
| Revenue Growth | N/A | ★ 309.82 |
| 52 Week Low | $2.33 | $2.82 |
| 52 Week High | $15.00 | $7.13 |
| Indicator | SIF | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 44.88 |
| Support Level | $5.92 | $3.13 |
| Resistance Level | N/A | $3.42 |
| Average True Range (ATR) | 1.38 | 0.17 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 65.25 | 18.95 |
SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.